New Delhi, 20th May 2021: The central govt said on Tuesday to begin trials of Bharat Biotech’s Covaxin for children. The third wave of a pandemic might come after few months which would affect children more. Viewing this, Covaxin has been approved by the DCGI for the 2nd and 3rd phase trials.

NITI Aayog member Dr VK Paul said, “Covaxin has been approved by DCGI for 2nd and 3rd phase trials on children for 2–18 years of age. This trial will begin in the next 10-12 days.”

Last Thursday, DCGI had permitted Bharat Biotech For 2nd and 3rd phase trials of Covaxin on children for 2- 18 years age group. The specialist committee recommended this trial. This trial will take place at several sites including AIIMS, Delhi, AIIMS, Patna and Meditrina institute of medical science, Nagpur. Bharat Biotech will conduct this trial with 525 volunteers.